— Know what they know.
Not Investment Advice

LNDC NASDAQ

Landec Corporation
1W: -3.0% 1M: +7.1% 3M: -24.2% 1Y: -7.9% 3Y: -19.5% 5Y: -28.5%
$8.76
Last traded 2022-11-14 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $263.6M mcap · 20M float · 0.327% daily turnover

📊 Key Metrics

TTM
$135M
Revenue
+23.4% YoY
$-32M
Net Income
-513.9% YoY
$-10M
Free Cash Flow
+46.0% YoY
25.0%
Gross Margin
-9.9%
Op. Margin
-32.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-178.7%
ROA-13.6%
ROIC291.4%

Valuation

P/E-5.5
P/B9.0
EV/EBITDA-10.8

Leverage

Debt/Equity0.00
Current Ratio2.84
Interest Cov.-11.4x

Quality Scores

Piotroski F5/9
Altman Z0.53
Beneish M-3.23

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms